Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Definitive HealthcareDH -5.09%49 EV-to-EBIT is -0.49 as of Jul. 21, 2026. GuruFocus rates DH with a GF Score™ of 49/100 and a GF Value™ of $4.43 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 468 Healthcare Providers & Services companies, Definitive Healthcare ranks worse than 213675% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Definitive Healthcare's Enterprise Value for the quarter that ended in Mar. 2026 was $165.7 Mil.
Definitive Healthcare's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-227.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Definitive Healthcare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Definitive Healthcare EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Definitive Healthcare's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Definitive Healthcare's EV-to-EBIT falls into.
Definitive Healthcare's current Enterprise Value is $112.2 Mil.
Definitive Healthcare's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-227.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Definitive Healthcare (DH) has a EV-to-EBIT of -0.49 as of Jul. 21, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Definitive Healthcare and its competitors. According to the industry distribution chart, Definitive Healthcare ranks #999999 out of 468 companies in the Healthcare Providers & Services industry.
Is Definitive Healthcare's EV-to-EBIT too high?
Definitive Healthcare's current EV-to-EBIT is -0.49. Based on the distribution chart, Definitive Healthcare ranks #999999 out of 468 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Definitive Healthcare has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Definitive Healthcare's EV-to-EBIT compare to DRIO and CCLD?
According to the Healthcare Providers & Services industry distribution chart, Definitive Healthcare ranks #999999 out of 468 companies for EV-to-EBIT. This places Definitive Healthcare in the lower half of its industry. The industry median EV-to-EBIT is 15.86. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.86, based on 468 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Definitive Healthcare and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Definitive Healthcare's current EV-to-EBIT is -0.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Definitive Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Definitive Healthcare (DH) is currently considered Possible Value Trap. The stock's GF Value™ is $4.43, compared to a current price of $0.74 — trading 83.3% below its estimated fair value. The current EV-to-EBIT is -0.49. Definitive Healthcare's overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Definitive Healthcare (DH), the current EV-to-EBIT is -0.49 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Definitive Healthcare (DH) Overvalued in 2026?
Based on GuruFocus' analysis, Definitive Healthcare stock appears to be undervalued.
The current stock price of $0.74 is trading 83.3% below its estimated GF Value™ of $4.43.
GuruFocus considers Definitive Healthcare to be Possible Value Trap.
Key valuation signals for DH:
EV-to-EBIT: -0.49
GF Value™: $4.43 vs. price of $0.74 (83.3% below fair value)
No single metric tells the full story. See the DH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.
49GF Score
Get the complete analysis for DH
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DH has been successfully added to your 
